The incidence of herpes zoster was 5.4 cases vs ... shorter in the vaccinated group (21 days vs. 24 days). Most vaccine adverse effects were mild, including varicella-like rashes at the injection ...

GSK plc (NYSE:GSK) released topline data from the phase 3 trial in adults 50 years and older evaluating the immunogenicity, ...

Melbourne, Australia The Government has expanded access to GSK's shingles vaccine, Shingrix, to cover individuals aged 18 ...

GlaxoSmithKline Pharmaceutical Sdn Bhd (GSK) today announced the launch of its Herpes Zoster vaccine, Shingrix ...

Researchers conducted an observational study to compare the risk for dementia associated with both the live and recombinant shingles vaccines.

Findings showed a noninferior immune response for both vaccines when Shingrix and Arexvy were coadministered compared with separate administration (primary endpoint). Both anti-gE antibody ...

Indication for SHINGRIX SHINGRIX is an FDA-approved vaccine for the prevention of shingles (herpes zoster) in: Adults 50 years and older. Adults 18 years and older who are or will be at increased risk ...

New Delhi: The Central Drugs Standard Control Organization (CDSCO) has published a list of the details of importers whose ...

Expert Rev Vaccines. 2010;9(3s):21-26. While there is still no standard definition for PHN, for the purposes of this review it is defined as: clinically significant pain or painful abnormal ...

Additionally, Dr. Brangman says that the Tdap vaccine, which protects against tetanus, diphtheria and whooping cough, is also ...

GSK has launched it's Shingles vaccine in Malaysia and here's all you need to know about it. From what it is, to the side ...

Shingrix is approved to prevent shingles (herpes zoster) in adults aged 50 and older ... Also Read: GSK Halts Herpes Simplex Virus Vaccine Development, Clears Path For Other Contenders Like ...